Other Events ·
Nasdaq delists Glucotrack for failing to maintain $1.00 minimum bid price after stock fell to $0.87
GCTKGlucotrack, Inc.
The Nasdaq Stock Market LLC has determined to delist Glucotrack, Inc.'s common stock from its exchange because the company failed to satisfy the terms of a compliance exception. The Nasdaq Hearings Panel issued written notice on October 28, 2026, citing a closing bid price of $0.87 on October 14, 2026, which breached the requirement to maintain at least $1.00 through November 9, 2026. Trading in the company's shares will be suspended at the open on October 30, 2026. Nasdaq is expected to file a Form 25 to deregister the securities under Section 12(b) of the Securities Exchange Act. The company plans for its shares to begin trading on the OTCID Market tier of the OTC Markets Group. Glucotrack develops and markets medical devices for diabetes management.